Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 8,196,000 | 6,903,000 | 6,986,000 | 6,105,000 | 6,839,000 |
| Cost of Goods | 3,112,000 | 1,806,000 | 1,813,000 | 1,720,000 | 1,747,000 |
| Gross Profit | 5,084,000 | 5,097,000 | 5,173,000 | 4,385,000 | 5,092,000 |
| Operating Expenses | 3,813,000 | 3,076,000 | 2,489,000 | 2,464,000 | 2,862,000 |
| Operating Income | 1,271,000 | 2,021,000 | 2,684,000 | 1,921,000 | 2,230,000 |
| Interest Expense | 821,000 | 759,000 | 752,000 | 543,000 | 415,000 |
| Other Income | 402,000 | 685,000 | -318,000 | 2,064,000 | -67,000 |
| Pre-tax Income | 852,000 | 1,947,000 | 1,614,000 | 3,442,000 | 1,748,000 |
| Income Tax | 85,000 | 217,000 | 235,000 | 601,000 | 132,000 |
| Net Income Continuous | 767,000 | 1,730,000 | 1,379,000 | 2,841,000 | 1,616,000 |
| Net Income | $767,000 | $1,730,000 | $1,379,000 | $2,841,000 | $1,616,000 |
| EPS Basic Total Ops | 1.43 | 3.23 | 2.58 | 5.32 | 3.02 |
| EPS Basic Continuous Ops | 1.42 | 3.23 | 2.58 | 5.32 | 3.02 |
| EPS Diluted Total Ops | 1.42 | 3.22 | 2.57 | 5.28 | 3.00 |
| EPS Diluted Continuous Ops | 1.42 | 3.22 | 2.57 | 5.28 | 3.00 |
| EPS Diluted Before Non-Recurring Items | 4.71 | 4.96 | 5.00 | 3.98 | 4.09 |
| EBITDA(a) | $2,651,000 | $2,916,000 | $3,580,000 | $2,821,000 | $3,141,000 |